META vs TMO: Which Is the Better Buy?
Side-by-side comparison of Meta Platforms, Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-20.
Meta Platforms, Inc. · Communication Services
$646.01
+43.0% upside to fair value
High Conviction
Grade A
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
META has more upside to fair value
(+43.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
META |
TMO |
| Current Price |
$646.01 |
$464.61 |
| Fair Value Estimate |
$924.09 |
$498.27 |
| Upside to Fair Value |
+43.0%
|
+7.2%
|
| Market Cap |
$1,639.8B |
$172.7B |
| Forward P/E |
—
|
25.2x
|
| EV / EBITDA |
15.0x
|
19.1x
|
| Price / Sales |
7.6x
|
3.8x
|
| Price / FCF |
33.9x
|
25.6x
|
| Revenue Growth YoY |
+33.1%
|
+6.2%
|
| Gross Margin |
81.9%
|
39.4%
|
| Operating Margin |
41.2%
|
17.8%
|
| Return on Equity |
33.2%
|
13.3%
|
| Dividend Yield |
0.33% |
0% |
| FCF Yield |
2.95%
|
3.91%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Meta Platforms operates the Facebook, Instagram, Messenger and WhatsApp ecosystem and monetizes its 3.56 billion Family daily active people primarily through digital advertising. Business quality is high: the core platform combines global network effects, advertiser measurement data, creator supply, cross-app distribution and AI-driven ad ranking, supporting 81.9% gross margin, 41.2% operating ma…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
META |
TMO |
| Zone Low |
$693.07 |
$373.70 |
| Zone High |
$785.48 |
$423.53 |
| In Buy Zone? |
Yes
|
No
|